Isomorphic Labs is an AI-driven drug discovery company founded by Demis Hassabis in 2021 as a spin-off from DeepMind. The company utilizes advanced AI models, including AlphaFold, to predict protein structures and interactions, aiming to revolutionize the drug discovery process. By modeling complex biological systems, Isomorphic Labs seeks to design novel therapeutics more efficiently. The company has established partnerships with pharmaceutical giants like Eli Lilly and Novartis and secured $600 million in funding to advance its mission of accelerating therapeutic development.

isomorphic-labs

An AI-driven drug discovery company leveraging AlphaFold to accelerate therapeutic development.

AI Agents with Google Cloud Tpus Integration

Isomorphic Labs